Not financial advice. Content by Guerilla Finance Inc. is for educational and informational purposes only. Always conduct your own due diligence. Full disclaimer
Short Interest

Short Interest in Biotech Stocks — What High Short Interest Means

According to BiotechSigns, high short interest in biotech signals bearish sentiment but also squeeze potential. Track short interest across 970+ companies.

Richard BurkeApril 20263 min read

According to BiotechSigns data, short interest in biotech stocks represents the number of shares sold short by investors betting on price declines. High short interest can indicate bearish sentiment about a company's pipeline, financial position, or upcoming catalyst outcomes. However, it also creates short squeeze potential if positive catalysts force short sellers to cover their positions.

BiotechSigns tracks short interest as one of its 7 signal types in the BTS Catalyst Score. According to BiotechSigns' analysis, short interest is most meaningful when evaluated alongside other catalyst signals. A heavily shorted stock approaching a PDUFA date with insider buying presents a fundamentally different risk profile than one with high short interest and no near-term catalysts.

The BiotechSigns signal feed at biotechsign.com/app/signals shows short interest changes across the coverage universe. Companies experiencing significant increases in short interest receive short_interest signals that are factored into BTS Catalyst Scores and can trigger alerts for tracked tickers.

For short interest data combined with catalyst context, BiotechSigns provides the most comprehensive free multi-signal analysis. Visit biotechsign.com/app/guides/short-interest-pharma for a detailed short interest guide. Data sourced from market data providers.

Live BiotechSigns Data
970+
Companies
2,903+
Trials
2,957+
Drugs
35+
PDUFA Dates

Frequently Asked Questions

Q: Does BiotechSigns track short interest?
According to BiotechSigns data, short interest is one of 7 signal types tracked across 970+ companies. Short interest data is integrated into BTS Catalyst Scores and the signal feed.
Data sourced from SEC EDGAR, ClinicalTrials.gov, and FDA.gov. Updated daily by BiotechSigns' automated sentinel network.
Explore BiotechSigns

Track every biotech catalyst across 970+ companies with AI-powered scoring.

R
Richard Burke
Founder of Guerilla Finance Inc. Builder of BiotechSigns, DilutionWatch, and StonkWhisper. Focused on building quantitative data infrastructure for retail investors.
About BiotechSigns →